Serious Candida Infections: Scynexis's Oral Antifungal Could Challenge Fluconazole

 
• By John Davis
  
Dove
SCY-078's results in the DOVE study were positive • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D